Certolızumab Pegol ELISA (mAb-based)

Enzyme immunoassay for the specific and quantitative determination of free Certolizumab Pegol (Cimzia®) in serum and plasma.

The solid phase (MTP) is coated by a highly specific monoclonal antibody directed against Certolizumab Pegol. Therefore any cross reactivity to the other therapeutical monoclonal antibodies is excluded.

Reference: IG-AB109

Barcode: 8682754930257

Intended Use: This kit has been developed for the measurement of drug levels in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.

Assay Design:

Related Documents

Instructions for Use IG-AB109 Download

Quality Control Certificates

Cimzia® is a trademark of  UCB.

Required Volume (µL)  10
Incubation Time (min)  160
Sample  Serum or Plasma
Package Size 96 Tests
Standard Range (µg/mL, 500x)  0-100
Detection Limit (ng/mL) 5
Spike Recovery (%) >95
Shelf Life (years) 2